期刊文献+

13例毛霉菌性肺炎调查分析 被引量:5

Pulmonary Mucormycosis in 13 Cases and Review of Literature
原文传递
导出
摘要 目的分析13例毛霉菌性肺炎的临床表现及诊治经过,了解毛霉菌性肺炎的疾病特点,为临床早期防治提供线索。方法对医院2002-2006年诊断的13例毛霉菌性肺炎患者(其中确诊病例1例,临床诊断病例12例)进行回顾性分析,分析毛霉菌性肺炎患者的临床和影像学表现、诊断、治疗效果及预后。结果毛霉菌性肺炎多发生于白血病、重症肝炎、糖尿病并酮症酸中毒等有严重基础疾病的患者;咳嗽、咳痰(76.9%)、咯血(53.8%)、呼吸困难(46.2%)及发热>38℃(53.8%)为主要临床表现;肺部渗出性阴影(69.2%)、空洞形成(38.5%)及胸腔积液(38.5%)为主要胸部影像学表现;多数患者其病情发展快,过程凶险,死亡率高达84.6%,疾病的愈后与基础疾病的严重程度密切相关。结论毛霉菌性肺炎临床表现无特异性,死亡率高,对具有高危因素的、临床抗感染无效的肺炎患者要怀疑毛霉菌性肺炎的诊断,早期病理学证据对于愈后尤为重要。 OBJECTIVE To analyze the clinical characterization of the pulmonary mucormycosis. METHODS All the cases were divided into proven cases(n= 1) and probable cases(n= 12) according to the definitions of Europen Organization for Research and Treatment of Cancer/National Institute of Allergy and Infectious Disease Mycosis Study Group(EORTC/MSG). Patient's symptoms, physical examinations, radiograph images and treatment were analyzed. RESULTS From the literature and the 13 cases, the underlying predisposing conditions of pulmonary mucormycosis were teukemia,neutropenia, diabetes mellitus with ketoacidosis, long term used corticosteroid and immunsuppression patients. Sputum(76.9%), hemoptysis(53.8%), dyspnea(46.2%)and fever(53.8%) were the most commonly symptoms. Infiltrate shadow(69.2 %), cavity(38.5 %) and pleural effusion(38.5%) were the most radiographic manifestations. Most of patients has associated with a dramatically worse outcome, the mean time from the positive result of mucormycosis to death were only 1-5 days with the mortality and of 84. 6%. CONCLUSIONS For patients with high-risk factors, especially for patients who had no effect after antibiotic therapy the pulmonary mucormycosis must be early suspicious. Histopathological examination is vital to early diagnosis and treatment.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2009年第15期1965-1968,共4页 Chinese Journal of Nosocomiology
关键词 真菌 毛霉菌性肺炎 Fungi Mucormycosis
  • 相关文献

参考文献9

  • 1Roden MM, Zaoutis TE, Buchanan WL,et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases [J]. Clin Infect Dis,2005,41:634-653.
  • 2Pagano L,Girmenia C, Mele L, et al. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program [J]. Haematologica,2001,86:862-870.
  • 3曹彬,蔡柏蔷,王辉,周朝阳,王澎,刘鸿瑞,张弘,徐凌,徐凯峰,许文兵,朱元珏,李晓光.肺部真菌感染152例病原谱再评价[J].中华结核和呼吸杂志,2007,30(4):279-283. 被引量:116
  • 4Ascioglu S,Rex JH,de Pauw B,et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoetic stem cell transplants: an international consensus[J]. Clin Infect Dis, 2002,34 : 7-14.
  • 5Marty EM,Cosimi L,Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem cell transplants[J]. N Engl J Med,2004,350 : 950-952.
  • 6KontoyiannisDP,LionakisMS,LewisRE,et al. Zygomycosis in the era of Aspergillus-active antifungal therapy in a tertiary care cancer center: a case-control observational study of 27 recent cases[J]. J Infect Dis,2005,191:1350-1360.
  • 7Francis Y, W Lee, Sherif B. Pulmonary mucormycosis: the last 30 years[J]. Arch Intern Med, 1999,159 : 1301-1309.
  • 8Georgios C,Edith MM, Russell EL,et al. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer[J]. Clin Infect Dis,2005,41: 60-66.
  • 9Spellberg B, Edwards J,Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management[J]. Clin Microbiol Rev, 2005,18: 556-569.

二级参考文献16

共引文献115

同被引文献30

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部